Cargando…
Bone destruction in chronic otitis media is not mediated by the RANKL pathway or estrogen receptor-alpha
BACKGROUND: Chronic otitis media with or without cholesteatoma progresses with various degrees of bone resorption and remodeling. Estrogen mediates osteoprotective effects through the receptor activator of NF-κB ligand (RANKL) pathway, which is mainly mediated by estrogen receptor-alpha (ER-α). OBJE...
Autores principales: | Heo, Kyung Wook, Noh, MinHye, Hur, Dae Young, Hong, Tae Ui, Park, Sung Yool, Kim, Woo Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498706/ https://www.ncbi.nlm.nih.gov/pubmed/37697808 http://dx.doi.org/10.1177/00368504231199204 |
Ejemplares similares
-
Regulation of RANKL signaling in arthritic bone destruction
por: Takayanagi, H
Publicado: (2003) -
Resolution of otitis media in a humanized mouse model
por: Son, Ye Lin, et al.
Publicado: (2022) -
Decreased Expression of Aquaporins in Otitis Media: What About Chronic Otitis Media?
por: Kim, Shin Hye, et al.
Publicado: (2019) -
Leukotriene B4 Is a Major Determinant of Leukocyte Recruitment During Otitis Media
por: Heo, Kyung Wook, et al.
Publicado: (2021) -
RANKL is a therapeutic target of bone destruction in rheumatoid arthritis
por: Tanaka, Sakae
Publicado: (2019)